You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 294 No. 14, October 12, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (62)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Lipids and Lipid Disorders
 •Alert me on articles by topic

Trends in Serum Lipids and Lipoproteins of Adults, 1960-2002

Margaret D. Carroll, MSPH; David A. Lacher, MD; Paul D. Sorlie, PhD; James I. Cleeman, MD; David J. Gordon, MD, PhD; Michael Wolz, MS; Scott M. Grundy, MD, PhD; Clifford L. Johnson, MSPH

JAMA. 2005;294:1773-1781.

Context  Serum total and low-density lipoprotein (LDL) cholesterol contribute significantly to atherosclerosis and its clinical sequelae. Previous analyses of data from the National Health and Nutrition Examination Surveys (NHANES) showed that mean levels of total cholesterol of US adults had declined from 1960-1962 to 1988-1994, and mean levels of LDL cholesterol (available beginning in 1976) had declined between 1976-1980 and 1988-1994.

Objective  To examine trends in serum lipid levels among US adults between 1960 and 2002, with a particular focus on changes since the 1988-1994 NHANES survey.

Design, Setting, and Participants  Blood lipid measurements taken from 6098 to 15 719 adults who were examined in 5 distinct cross-sectional surveys of the US population during 1960-1962, 1971-1974, 1976-1980, 1988-1994, and 1999-2002.

Main Outcome Measures  Mean serum total cholesterol, LDL cholesterol, high-density lipoprotein (HDL) cholesterol, and geometric mean serum triglyceride levels, and the percentage of adults with a serum total cholesterol level of at least 240 mg/dL (≥6.22 mmol/L).

Results  Between 1988-1994 and 1999-2002, total serum cholesterol level of adults aged 20 years or older decreased from 206 mg/dL (5.34 mmol/L) to 203 mg/dL (5.26 mmol/L) (P=.009) and LDL cholesterol levels decreased from 129 mg/dL (3.34 mmol/L) to 123 mg/dL (3.19 mmol/L) (P<.001). Greater and significant decreases were observed in men 60 years or older and in women 50 years or older. The percentage of adults with a total cholesterol level of at least 240 mg/dL (≥6.22 mmol/L) decreased from 20% during 1988-1994 to 17% during 1999-2002 (P<.001). There was no change in mean HDL cholesterol levels and a nonsignificant increase in geometric mean serum triglyceride levels (P = .06).

Conclusions  The decrease in total cholesterol level observed during 1960-1994 and LDL cholesterol level observed during 1976-1994 has continued during 1999-2002 in men 60 to 74 years and women 50 to 74 years. The target value of no more than 17% of US adults with a total cholesterol level of at least 240 mg/dL (≥6.22 mmol/L), an objective of Healthy People 2010, has been attained. The increase in the proportion of adults using lipid-lowering medication, particularly in older age groups, likely contributed to the decreases in total and LDL cholesterol levels observed. The increased prevalence of obesity in the US population may have contributed to the increase in mean serum triglyceride levels.


Author Affiliations: National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, Md (Dr Lacher and Ms Carroll and Mr Johnson); National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md (Drs Sorlie, Cleeman, and Gordon, and Mr Wolz); and University of Texas Southwestern Medical Center, Dallas (Dr Grundy).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Trends in the incidence of coronary heart disease and stroke and their risk factors in Japan, 1964 to 2003 the akita-osaka study.
Kitamura et al.
J Am Coll Cardiol 2008;52:71-79.
FULL TEXT  

Trends in Diabetes, High Cholesterol, and Hypertension in Chronic Kidney Disease Among U.S. Adults: 1988-1994 to 1999-2004
Fox and Muntner
Diabetes Care 2008;31:1337-1342.
ABSTRACT | FULL TEXT  

Use of Ezetimibe in the United States and Canada
Jackevicius et al.
NEJM 2008;358:1819-1828.
ABSTRACT | FULL TEXT  

Surrogate End Points and FDA Approval: A Tale of 2 Lipid-Altering Drugs
Psaty and Lumley
JAMA 2008;299:1474-1476.
FULL TEXT  

A changing paradigm for prevention of cardiovascular disease: emergence of the metabolic syndrome as a multiplex risk factor
Grundy
Eur Heart J Suppl 2008;10:B16-B23.
ABSTRACT | FULL TEXT  

Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Rosamond et al.
Circulation 2008;117:e25-e146.
FULL TEXT  

Evidence for a quantitative trait locus affecting low levels of apolipoprotein B and low density lipoprotein on chromosome 10 in Caucasian families
Sherva et al.
J. Lipid Res. 2007;48:2632-2639.
ABSTRACT | FULL TEXT  

Coronary Heart Disease Mortality Among Young Adults in the U.S. From 1980 Through 2002: Concealed Leveling of Mortality Rates
Ford and Capewell
J Am Coll Cardiol 2007;50:2128-2132.
ABSTRACT | FULL TEXT  

Changes in Triglyceride Levels and Risk for Coronary Heart Disease in Young Men
Tirosh et al.
ANN INTERN MED 2007;147:377-385.
ABSTRACT | FULL TEXT  

The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: Design, Recruitment, and Initial Examination
Splansky et al.
Am J Epidemiol 2007;165:1328-1335.
ABSTRACT | FULL TEXT  

Implications of Cardiac Risk and Low-Density Lipoprotein Cholesterol Distributions in the United States for the Diagnosis and Treatment of Dyslipidemia: Data From National Health and Nutrition Examination Survey 1999 to 2002
Keevil et al.
Circulation 2007;115:1363-1370.
ABSTRACT | FULL TEXT  

Cardiovascular disease prevention in primary care
Chauhan
Br Med Bull 2007;0:ldm002v1-15.
ABSTRACT | FULL TEXT  

Heart Disease and Stroke Statistics--2007 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Rosamond et al.
Circulation 2007;115:e69-e171.
FULL TEXT  

An Overview Of Cardiovascular Disease Burden In The United States
Mensah and Brown
Health Aff (Millwood) 2007;26:38-48.
ABSTRACT | FULL TEXT  

The Year in Epidemiology, Health Services Research, and Outcomes Research
Krumholz and Masoudi
J Am Coll Cardiol 2006;48:1886-1895.
FULL TEXT  

Reduction in Cholesterol Absorption Is Enhanced by Stearate-Enriched Plant Sterol Esters in Hamsters
Rasmussen et al.
J. Nutr. 2006;136:2722-2727.
ABSTRACT | FULL TEXT  

The Chronic Kidney Disease Epidemic: Stepping Back and Looking Forward
Kiberd
J. Am. Soc. Nephrol. 2006;17:2967-2973.
ABSTRACT | FULL TEXT  

A randomized factorial study of the effects of long-term garlic and micronutrient supplementation and of 2-wk antibiotic treatment for Helicobacter pylori infection on serum cholesterol and lipoproteins.
Zhang et al.
Am. J. Clin. Nutr. 2006;84:912-919.
ABSTRACT | FULL TEXT  

Options for therapeutic intervention: how effective are the different agents?
Barter
Eur Heart J Suppl 2006;8:F47-F53.
ABSTRACT | FULL TEXT  

The Unchanging Incidence and Case-Fatality of Stroke in the 1990s: A Population-Based Study
Kleindorfer et al.
Stroke 2006;37:2473-2478.
ABSTRACT | FULL TEXT  

Improving medication adherence: challenges for physicians, payers, and policy makers.
O'Connor
Arch Intern Med 2006;166:1802-1804.
FULL TEXT  

Meta-Analysis of Cardiovascular Outcomes Trials Comparing Intensive Versus Moderate Statin Therapy
Cannon et al.
J Am Coll Cardiol 2006;48:438-445.
ABSTRACT | FULL TEXT  

Comparison of Low-Fat Meal and High-Fat Meal on Postprandial Lipemic Response in Non-Obese Men according to the -1131T>C Polymorphism of the Apolipoprotein A5 (APOA5) Gene (Randomized Cross-Over Design).
Kim et al.
J. Am. Coll. Nutr. 2006;25:340-347.
ABSTRACT | FULL TEXT  

Plasma apolipoproteins and risk for age related maculopathy
Dashti et al.
Br. J. Ophthalmol. 2006;90:1028-1033.
ABSTRACT | FULL TEXT  

Introduction: Pharmacotherapy for Dyslipidemia
Dumo
Journal of Pharmacy Practice 2006;19:61-62.
 

Protease variants, LDL, and coronary heart disease.
Tall
NEJM 2006;354:1310-1312.
FULL TEXT  

Preventing coronary heart disease.
Jackson et al.
BMJ 2006;332:617-618.
FULL TEXT  

Heart Disease and Stroke Statistics--2006 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Thom et al.
Circulation 2006;113:e85-e151.
FULL TEXT  

Prevention of Coronary Heart Disease and the National Cholesterol Education Program
Kuller
Circulation 2006;113:598-600.
FULL TEXT  

Cholesterol Levels Continue to Decline
Journal Watch Cardiology 2005;2005:2-2.
FULL TEXT  

What's new in the other general journals
Tonks
BMJ 2005;331:927-928.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.